Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 20.89%6.08M | 27.75%5.52M | 20.42%4.21M | 45.43%17.53M | 45.46%4.68M | 63.58%5.03M | 39.99%4.32M | 30.82%3.5M | 20.25%12.05M | 41.00%3.22M |
| Operating revenue | 20.89%6.08M | 27.75%5.52M | 20.42%4.21M | 45.43%17.53M | 45.46%4.68M | 63.58%5.03M | 39.99%4.32M | 30.82%3.5M | 20.25%12.05M | 41.00%3.22M |
| Cost of revenue | 12.45%4.06M | 40.19%4.08M | 21.42%2.62M | 57.74%11.71M | 53.85%3.03M | 97.77%3.61M | 44.84%2.91M | 33.34%2.16M | 14.59%7.42M | 46.38%1.97M |
| Gross profit | 42.28%2.02M | 2.10%1.44M | 18.81%1.6M | 25.72%5.83M | 32.20%1.65M | 13.71%1.42M | 30.95%1.41M | 26.97%1.34M | 30.57%4.63M | 33.26%1.25M |
| Operating expense | 56.28%1.37M | 30.27%1.23M | 22.77%1.32M | 9.06%4.06M | 16.88%1.16M | -1.40%876.81K | -0.75%947.24K | 20.82%1.07M | 20.62%3.72M | 22.49%994.38K |
| Selling and administrative expenses | 32.50%1.15M | 28.86%1.02M | 29.84%1.15M | 22.01%3.6M | 29.44%1.05M | 19.00%867.08K | 11.90%793.33K | 26.19%885.88K | 20.47%2.95M | 24.05%813.67K |
| -Selling and marketing expense | 64.21%56.89K | -66.18%18.52K | -7.98%121.87K | 12.69%338.04K | 143.22%116.18K | -55.12%34.65K | -38.41%54.77K | 53.84%132.43K | 68.23%299.98K | 2.51%47.77K |
| -General and administrative expense | 31.18%1.09M | 35.90%1M | 36.48%1.03M | 23.06%3.26M | 22.34%937.02K | 27.79%832.44K | 19.11%738.56K | 22.33%753.45K | 16.72%2.65M | 25.69%765.9K |
| Research and development costs | 1,360.82%157.54K | -3.54%116.57K | -12.85%129.97K | -51.47%330.78K | -47.56%73.29K | -108.67%-12.5K | -47.55%120.85K | -10.89%149.14K | 33.03%681.65K | 0.46%139.74K |
| Depreciation amortization depletion | 82.81%63.79K | 165.79%87.7K | -2.34%35.55K | -10.01%139.2K | -9.71%34.91K | -9.77%34.89K | -14.67%32.99K | -5.87%36.4K | -16.83%154.68K | -5.37%38.67K |
| -Depreciation and amortization | 82.81%63.79K | 165.79%87.7K | -2.34%35.55K | -10.01%139.2K | -9.71%34.91K | -9.77%34.89K | -14.67%32.99K | -5.87%36.4K | -16.83%154.68K | -5.37%38.67K |
| Other operating expenses | ---- | 11,424.62%7.49K | -82.50%56 | 81.94%-11.89K | -65.87%787 | 42.83%-12.68K | 100.27%65 | 101.52%320 | -5.21%-65.81K | 109.57%2.31K |
| Operating profit | 19.78%653.2K | -55.41%206.92K | 3.18%280.23K | 93.71%1.77M | 92.49%486.37K | 50.89%545.34K | 276.38%464.03K | 58.86%271.59K | 96.80%912.34K | 103.80%252.67K |
| Net non-operating interest income (expenses) | -145.99%-4.44K | -119.08%-2.64K | 4.44%9.71K | 400.09%43.01K | 16.68%10.23K | -4.38%9.66K | 339.15%13.82K | 305.78%9.3K | 135.00%8.6K | 343.39%8.77K |
| Non-operating interest income | -66.99%8.76K | -59.12%12.55K | -4.48%25.31K | 50.93%111.2K | 4.49%27.47K | 3.25%26.53K | 177.26%30.71K | 149.49%26.5K | 174.80%73.68K | 142.17%26.29K |
| Non-operating interest expense | -21.76%13.2K | -10.02%15.19K | -9.30%15.6K | 4.79%68.19K | -1.60%17.24K | 8.19%16.87K | 0.17%16.88K | 13.61%17.2K | 26.66%65.08K | 21.18%17.52K |
| Other net income (expenses) | 112.35%10.64K | 172.08%220.5K | -170.21%-84.52K | -350.09%-414.26K | -575.36%-529.5K | -306.46%-86.18K | 413.10%81.04K | 508.15%120.38K | -205.64%-92.04K | -528.66%-78.4K |
| Gain on sale of security | 112.35%10.64K | 220.49%240.5K | -124.94%-32.52K | -216.10%-408.31K | -458.24%-527.55K | -306.46%-86.18K | 215.60%75.04K | 1,234.33%130.38K | -229.21%-129.17K | -616.69%-94.5K |
| Special income (charges) | --0 | -433.33%-20K | -420.00%-52K | -116.02%-5.95K | -112.10%-1.95K | --0 | -84.63%6K | 44.44%-10K | 389.02%37.13K | --16.1K |
| -Less:Write off | --0 | 433.33%20K | 420.00%52K | 116.02%5.95K | 112.10%1.95K | --0 | 84.63%-6K | -44.44%10K | -389.02%-37.13K | ---16.1K |
| Income before tax | 40.65%659.4K | -24.00%424.78K | -48.81%205.42K | 68.42%1.4M | -117.97%-32.9K | 13.44%468.82K | 509.99%558.89K | 184.69%401.27K | 57.55%828.9K | 32.02%183.07K |
| Income tax | 38.81%204.41K | -76.86%33.18K | 38.46%109.53K | 112.20%582.02K | 122.52%212.26K | 12.69%147.26K | 1,263.05%143.39K | 109.93%79.11K | 117.59%274.28K | 106.12%95.39K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 41.50%454.99K | -5.75%391.6K | -70.24%95.89K | 46.78%814.05K | -379.61%-245.16K | 13.79%321.55K | 412.31%415.5K | 211.97%322.16K | -73.40%554.63K | -94.84%87.68K |
| Net income continuous operations | 41.50%454.99K | -5.75%391.6K | -70.24%95.89K | 46.78%814.05K | -379.61%-245.16K | 13.79%321.55K | 412.31%415.5K | 211.97%322.16K | -73.40%554.63K | -94.84%87.68K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 41.50%454.99K | -5.75%391.6K | -70.24%95.89K | 46.78%814.05K | -379.61%-245.16K | 13.79%321.55K | 412.31%415.5K | 211.97%322.16K | -73.40%554.63K | -94.84%87.68K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 41.50%454.99K | -5.75%391.6K | -70.24%95.89K | 46.78%814.05K | -379.61%-245.16K | 13.79%321.55K | 412.31%415.5K | 211.97%322.16K | -73.40%554.63K | -94.84%87.68K |
| Diluted earnings per share | 0.01 | 0 | 0 | 0.00%0.01 | 0 | 0 | 0 | 0 | -50.00%0.01 | 0 |
| Basic earnings per share | 0.01 | 0 | 0 | 0.00%0.01 | 0 | 0 | 0 | 0 | -50.00%0.01 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.